nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Temsirolimus—kidney cancer	0.0874	0.119	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0874	0.119	CbGbCtD
Alprazolam—CYP3A5—Temsirolimus—kidney cancer	0.0656	0.0894	CbGbCtD
Alprazolam—CYP3A4—Everolimus—kidney cancer	0.0379	0.0516	CbGbCtD
Alprazolam—CYP3A7—Paclitaxel—kidney cancer	0.03	0.0409	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.03	0.0409	CbGbCtD
Alprazolam—CYP3A7—Sorafenib—kidney cancer	0.0267	0.0363	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0267	0.0363	CbGbCtD
Alprazolam—CYP3A7—Vincristine—kidney cancer	0.0259	0.0353	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0259	0.0353	CbGbCtD
Alprazolam—CYP3A4—Temsirolimus—kidney cancer	0.0256	0.0349	CbGbCtD
Alprazolam—CYP3A5—Erlotinib—kidney cancer	0.0246	0.0335	CbGbCtD
Alprazolam—CYP2C9—Capecitabine—kidney cancer	0.0241	0.0329	CbGbCtD
Alprazolam—CYP3A5—Paclitaxel—kidney cancer	0.0225	0.0307	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0216	0.0294	CbGbCtD
Alprazolam—CYP3A7—Sunitinib—kidney cancer	0.0216	0.0294	CbGbCtD
Alprazolam—CYP3A5—Sorafenib—kidney cancer	0.02	0.0273	CbGbCtD
Alprazolam—CYP3A5—Vincristine—kidney cancer	0.0194	0.0265	CbGbCtD
Alprazolam—CYP3A5—Sunitinib—kidney cancer	0.0162	0.0221	CbGbCtD
Alprazolam—CYP2C9—Paclitaxel—kidney cancer	0.0151	0.0206	CbGbCtD
Alprazolam—CYP3A4—Pazopanib—kidney cancer	0.0134	0.0183	CbGbCtD
Alprazolam—CYP2C9—Sorafenib—kidney cancer	0.0134	0.0183	CbGbCtD
Alprazolam—CYP3A4—Erlotinib—kidney cancer	0.00959	0.0131	CbGbCtD
Alprazolam—CYP3A4—Paclitaxel—kidney cancer	0.00878	0.012	CbGbCtD
Alprazolam—CYP3A4—Sorafenib—kidney cancer	0.0078	0.0106	CbGbCtD
Alprazolam—CYP3A4—Vinblastine—kidney cancer	0.0077	0.0105	CbGbCtD
Alprazolam—CYP3A4—Vincristine—kidney cancer	0.00757	0.0103	CbGbCtD
Alprazolam—CYP3A4—Sunitinib—kidney cancer	0.00632	0.00861	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—kidney cancer	0.00473	0.00645	CbGbCtD
Alprazolam—Diplopia—Doxorubicin—kidney cancer	0.000153	0.00062	CcSEcCtD
Alprazolam—Pain in extremity—Doxorubicin—kidney cancer	0.000153	0.00062	CcSEcCtD
Alprazolam—Osteoarthritis—Doxorubicin—kidney cancer	0.000153	0.00062	CcSEcCtD
Alprazolam—Paraesthesia—Gemcitabine—kidney cancer	0.000152	0.000618	CcSEcCtD
Alprazolam—Cardiac disorder—Capecitabine—kidney cancer	0.000152	0.000618	CcSEcCtD
Alprazolam—Asthenia—Sunitinib—kidney cancer	0.000151	0.000615	CcSEcCtD
Alprazolam—Dyspnoea—Gemcitabine—kidney cancer	0.000151	0.000614	CcSEcCtD
Alprazolam—Nausea—Vinblastine—kidney cancer	0.000151	0.000612	CcSEcCtD
Alprazolam—Somnolence—Gemcitabine—kidney cancer	0.000151	0.000612	CcSEcCtD
Alprazolam—Convulsion—Paclitaxel—kidney cancer	0.000151	0.000612	CcSEcCtD
Alprazolam—Affect lability—Doxorubicin—kidney cancer	0.00015	0.00061	CcSEcCtD
Alprazolam—Nausea—Everolimus—kidney cancer	0.00015	0.00061	CcSEcCtD
Alprazolam—Diarrhoea—Sorafenib—kidney cancer	0.00015	0.00061	CcSEcCtD
Alprazolam—Pruritus—Sunitinib—kidney cancer	0.000149	0.000607	CcSEcCtD
Alprazolam—Angiopathy—Capecitabine—kidney cancer	0.000149	0.000604	CcSEcCtD
Alprazolam—Myalgia—Paclitaxel—kidney cancer	0.000148	0.000601	CcSEcCtD
Alprazolam—Arthralgia—Paclitaxel—kidney cancer	0.000148	0.000601	CcSEcCtD
Alprazolam—Chest pain—Paclitaxel—kidney cancer	0.000148	0.000601	CcSEcCtD
Alprazolam—Mediastinal disorder—Capecitabine—kidney cancer	0.000148	0.0006	CcSEcCtD
Alprazolam—Anxiety—Paclitaxel—kidney cancer	0.000147	0.000599	CcSEcCtD
Alprazolam—Decreased appetite—Gemcitabine—kidney cancer	0.000147	0.000598	CcSEcCtD
Alprazolam—Hypersensitivity—Dactinomycin—kidney cancer	0.000147	0.000598	CcSEcCtD
Alprazolam—Chills—Capecitabine—kidney cancer	0.000147	0.000597	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000147	0.000597	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000146	0.000594	CcSEcCtD
Alprazolam—Discomfort—Paclitaxel—kidney cancer	0.000146	0.000594	CcSEcCtD
Alprazolam—Fatigue—Gemcitabine—kidney cancer	0.000146	0.000593	CcSEcCtD
Alprazolam—Gastrointestinal pain—Vincristine—kidney cancer	0.000146	0.000593	CcSEcCtD
Alprazolam—Dizziness—Sorafenib—kidney cancer	0.000145	0.000589	CcSEcCtD
Alprazolam—Constipation—Gemcitabine—kidney cancer	0.000145	0.000588	CcSEcCtD
Alprazolam—Nausea—Erlotinib—kidney cancer	0.000145	0.000588	CcSEcCtD
Alprazolam—Dry mouth—Paclitaxel—kidney cancer	0.000145	0.000588	CcSEcCtD
Alprazolam—Mood swings—Doxorubicin—kidney cancer	0.000145	0.000587	CcSEcCtD
Alprazolam—Diarrhoea—Sunitinib—kidney cancer	0.000144	0.000587	CcSEcCtD
Alprazolam—Ataxia—Doxorubicin—kidney cancer	0.000144	0.000583	CcSEcCtD
Alprazolam—Mental disorder—Capecitabine—kidney cancer	0.000144	0.000583	CcSEcCtD
Alprazolam—Asthenia—Dactinomycin—kidney cancer	0.000143	0.000583	CcSEcCtD
Alprazolam—Confusional state—Paclitaxel—kidney cancer	0.000143	0.000581	CcSEcCtD
Alprazolam—Malnutrition—Capecitabine—kidney cancer	0.000143	0.000579	CcSEcCtD
Alprazolam—Oedema—Paclitaxel—kidney cancer	0.000142	0.000576	CcSEcCtD
Alprazolam—Abdominal pain—Vincristine—kidney cancer	0.000141	0.000573	CcSEcCtD
Alprazolam—Body temperature increased—Vincristine—kidney cancer	0.000141	0.000573	CcSEcCtD
Alprazolam—Liver function test abnormal—Doxorubicin—kidney cancer	0.000141	0.000572	CcSEcCtD
Alprazolam—Infection—Paclitaxel—kidney cancer	0.000141	0.000572	CcSEcCtD
Alprazolam—Dizziness—Sunitinib—kidney cancer	0.00014	0.000567	CcSEcCtD
Alprazolam—Feeling abnormal—Gemcitabine—kidney cancer	0.00014	0.000567	CcSEcCtD
Alprazolam—Shock—Paclitaxel—kidney cancer	0.00014	0.000567	CcSEcCtD
Alprazolam—Vomiting—Sorafenib—kidney cancer	0.000139	0.000567	CcSEcCtD
Alprazolam—Nervous system disorder—Paclitaxel—kidney cancer	0.000139	0.000565	CcSEcCtD
Alprazolam—Tachycardia—Paclitaxel—kidney cancer	0.000138	0.000562	CcSEcCtD
Alprazolam—Rash—Sorafenib—kidney cancer	0.000138	0.000562	CcSEcCtD
Alprazolam—Dermatitis—Sorafenib—kidney cancer	0.000138	0.000561	CcSEcCtD
Alprazolam—Back pain—Capecitabine—kidney cancer	0.000138	0.00056	CcSEcCtD
Alprazolam—Breast disorder—Doxorubicin—kidney cancer	0.000138	0.00056	CcSEcCtD
Alprazolam—Skin disorder—Paclitaxel—kidney cancer	0.000138	0.00056	CcSEcCtD
Alprazolam—Headache—Sorafenib—kidney cancer	0.000137	0.000558	CcSEcCtD
Alprazolam—Muscle spasms—Capecitabine—kidney cancer	0.000137	0.000557	CcSEcCtD
Alprazolam—Hyperhidrosis—Paclitaxel—kidney cancer	0.000137	0.000557	CcSEcCtD
Alprazolam—Diarrhoea—Dactinomycin—kidney cancer	0.000137	0.000556	CcSEcCtD
Alprazolam—Nasopharyngitis—Doxorubicin—kidney cancer	0.000136	0.000554	CcSEcCtD
Alprazolam—Anorexia—Paclitaxel—kidney cancer	0.000135	0.000549	CcSEcCtD
Alprazolam—Muscular weakness—Doxorubicin—kidney cancer	0.000135	0.000547	CcSEcCtD
Alprazolam—Vision blurred—Capecitabine—kidney cancer	0.000134	0.000546	CcSEcCtD
Alprazolam—Vomiting—Sunitinib—kidney cancer	0.000134	0.000545	CcSEcCtD
Alprazolam—Body temperature increased—Gemcitabine—kidney cancer	0.000134	0.000544	CcSEcCtD
Alprazolam—Tremor—Capecitabine—kidney cancer	0.000134	0.000543	CcSEcCtD
Alprazolam—Rash—Sunitinib—kidney cancer	0.000133	0.000541	CcSEcCtD
Alprazolam—Dermatitis—Sunitinib—kidney cancer	0.000133	0.00054	CcSEcCtD
Alprazolam—Hypotension—Paclitaxel—kidney cancer	0.000133	0.000538	CcSEcCtD
Alprazolam—Ill-defined disorder—Capecitabine—kidney cancer	0.000132	0.000538	CcSEcCtD
Alprazolam—Headache—Sunitinib—kidney cancer	0.000132	0.000537	CcSEcCtD
Alprazolam—Dysphagia—Doxorubicin—kidney cancer	0.000132	0.000536	CcSEcCtD
Alprazolam—Influenza—Doxorubicin—kidney cancer	0.000132	0.000536	CcSEcCtD
Alprazolam—Hypersensitivity—Vincristine—kidney cancer	0.000132	0.000534	CcSEcCtD
Alprazolam—Nausea—Sorafenib—kidney cancer	0.00013	0.000529	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000129	0.000525	CcSEcCtD
Alprazolam—Malaise—Capecitabine—kidney cancer	0.000129	0.000522	CcSEcCtD
Alprazolam—Insomnia—Paclitaxel—kidney cancer	0.000128	0.000521	CcSEcCtD
Alprazolam—Vertigo—Capecitabine—kidney cancer	0.000128	0.00052	CcSEcCtD
Alprazolam—Asthenia—Vincristine—kidney cancer	0.000128	0.00052	CcSEcCtD
Alprazolam—Syncope—Capecitabine—kidney cancer	0.000128	0.00052	CcSEcCtD
Alprazolam—Paraesthesia—Paclitaxel—kidney cancer	0.000127	0.000517	CcSEcCtD
Alprazolam—Vomiting—Dactinomycin—kidney cancer	0.000127	0.000516	CcSEcCtD
Alprazolam—Dyspnoea—Paclitaxel—kidney cancer	0.000126	0.000514	CcSEcCtD
Alprazolam—Somnolence—Paclitaxel—kidney cancer	0.000126	0.000512	CcSEcCtD
Alprazolam—Palpitations—Capecitabine—kidney cancer	0.000126	0.000512	CcSEcCtD
Alprazolam—Rash—Dactinomycin—kidney cancer	0.000126	0.000512	CcSEcCtD
Alprazolam—Nausea—Sunitinib—kidney cancer	0.000125	0.000509	CcSEcCtD
Alprazolam—Loss of consciousness—Capecitabine—kidney cancer	0.000125	0.000509	CcSEcCtD
Alprazolam—Dyspepsia—Paclitaxel—kidney cancer	0.000125	0.000507	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—kidney cancer	0.000123	0.000501	CcSEcCtD
Alprazolam—Decreased appetite—Paclitaxel—kidney cancer	0.000123	0.000501	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000123	0.000498	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000122	0.000497	CcSEcCtD
Alprazolam—Fatigue—Paclitaxel—kidney cancer	0.000122	0.000497	CcSEcCtD
Alprazolam—Diarrhoea—Vincristine—kidney cancer	0.000122	0.000496	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—kidney cancer	0.000122	0.000495	CcSEcCtD
Alprazolam—Asthenia—Gemcitabine—kidney cancer	0.000122	0.000494	CcSEcCtD
Alprazolam—Arthralgia—Capecitabine—kidney cancer	0.000121	0.000493	CcSEcCtD
Alprazolam—Myalgia—Capecitabine—kidney cancer	0.000121	0.000493	CcSEcCtD
Alprazolam—Chest pain—Capecitabine—kidney cancer	0.000121	0.000493	CcSEcCtD
Alprazolam—Constipation—Paclitaxel—kidney cancer	0.000121	0.000493	CcSEcCtD
Alprazolam—Anxiety—Capecitabine—kidney cancer	0.000121	0.000492	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000121	0.00049	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00012	0.000489	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—kidney cancer	0.00012	0.000488	CcSEcCtD
Alprazolam—Discomfort—Capecitabine—kidney cancer	0.00012	0.000487	CcSEcCtD
Alprazolam—Pruritus—Gemcitabine—kidney cancer	0.00012	0.000487	CcSEcCtD
Alprazolam—Weight decreased—Doxorubicin—kidney cancer	0.000119	0.000485	CcSEcCtD
Alprazolam—Dry mouth—Capecitabine—kidney cancer	0.000119	0.000482	CcSEcCtD
Alprazolam—Nausea—Dactinomycin—kidney cancer	0.000119	0.000482	CcSEcCtD
Alprazolam—Dizziness—Vincristine—kidney cancer	0.000118	0.00048	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—kidney cancer	0.000118	0.000478	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—kidney cancer	0.000118	0.000478	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—kidney cancer	0.000118	0.000478	CcSEcCtD
Alprazolam—Confusional state—Capecitabine—kidney cancer	0.000117	0.000477	CcSEcCtD
Alprazolam—Feeling abnormal—Paclitaxel—kidney cancer	0.000117	0.000475	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000117	0.000474	CcSEcCtD
Alprazolam—Oedema—Capecitabine—kidney cancer	0.000116	0.000473	CcSEcCtD
Alprazolam—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000116	0.000471	CcSEcCtD
Alprazolam—Diarrhoea—Gemcitabine—kidney cancer	0.000116	0.000471	CcSEcCtD
Alprazolam—Infection—Capecitabine—kidney cancer	0.000116	0.00047	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—kidney cancer	0.000115	0.000466	CcSEcCtD
Alprazolam—Shock—Capecitabine—kidney cancer	0.000114	0.000465	CcSEcCtD
Alprazolam—Nervous system disorder—Capecitabine—kidney cancer	0.000114	0.000464	CcSEcCtD
Alprazolam—Tachycardia—Capecitabine—kidney cancer	0.000114	0.000461	CcSEcCtD
Alprazolam—Vomiting—Vincristine—kidney cancer	0.000114	0.000461	CcSEcCtD
Alprazolam—Skin disorder—Capecitabine—kidney cancer	0.000113	0.000459	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—kidney cancer	0.000113	0.000458	CcSEcCtD
Alprazolam—Urticaria—Paclitaxel—kidney cancer	0.000113	0.000458	CcSEcCtD
Alprazolam—Rash—Vincristine—kidney cancer	0.000113	0.000457	CcSEcCtD
Alprazolam—Hyperhidrosis—Capecitabine—kidney cancer	0.000113	0.000457	CcSEcCtD
Alprazolam—Dermatitis—Vincristine—kidney cancer	0.000112	0.000457	CcSEcCtD
Alprazolam—Body temperature increased—Paclitaxel—kidney cancer	0.000112	0.000455	CcSEcCtD
Alprazolam—Abdominal pain—Paclitaxel—kidney cancer	0.000112	0.000455	CcSEcCtD
Alprazolam—Headache—Vincristine—kidney cancer	0.000112	0.000454	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000111	0.000452	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—kidney cancer	0.000111	0.000451	CcSEcCtD
Alprazolam—Anorexia—Capecitabine—kidney cancer	0.000111	0.000451	CcSEcCtD
Alprazolam—Hypotension—Capecitabine—kidney cancer	0.000109	0.000442	CcSEcCtD
Alprazolam—Vomiting—Gemcitabine—kidney cancer	0.000108	0.000438	CcSEcCtD
Alprazolam—Rash—Gemcitabine—kidney cancer	0.000107	0.000434	CcSEcCtD
Alprazolam—Dermatitis—Gemcitabine—kidney cancer	0.000107	0.000433	CcSEcCtD
Alprazolam—Headache—Gemcitabine—kidney cancer	0.000106	0.000431	CcSEcCtD
Alprazolam—Nausea—Vincristine—kidney cancer	0.000106	0.000431	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000106	0.000431	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—kidney cancer	0.000106	0.000429	CcSEcCtD
Alprazolam—Insomnia—Capecitabine—kidney cancer	0.000105	0.000428	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—kidney cancer	0.000105	0.000427	CcSEcCtD
Alprazolam—Paraesthesia—Capecitabine—kidney cancer	0.000104	0.000425	CcSEcCtD
Alprazolam—Hypersensitivity—Paclitaxel—kidney cancer	0.000104	0.000424	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—kidney cancer	0.000104	0.000424	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—kidney cancer	0.000104	0.000423	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—kidney cancer	0.000104	0.000422	CcSEcCtD
Alprazolam—Dyspnoea—Capecitabine—kidney cancer	0.000104	0.000422	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—kidney cancer	0.000104	0.000421	CcSEcCtD
Alprazolam—Dyspepsia—Capecitabine—kidney cancer	0.000102	0.000416	CcSEcCtD
Alprazolam—Asthenia—Paclitaxel—kidney cancer	0.000102	0.000413	CcSEcCtD
Alprazolam—Decreased appetite—Capecitabine—kidney cancer	0.000101	0.000411	CcSEcCtD
Alprazolam—Nausea—Gemcitabine—kidney cancer	0.000101	0.000409	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Capecitabine—kidney cancer	0.0001	0.000408	CcSEcCtD
Alprazolam—Fatigue—Capecitabine—kidney cancer	0.0001	0.000408	CcSEcCtD
Alprazolam—Pruritus—Paclitaxel—kidney cancer	0.0001	0.000408	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—kidney cancer	9.98e-05	0.000406	CcSEcCtD
Alprazolam—Constipation—Capecitabine—kidney cancer	9.95e-05	0.000404	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—kidney cancer	9.87e-05	0.000401	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—kidney cancer	9.84e-05	0.0004	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—kidney cancer	9.8e-05	0.000398	CcSEcCtD
Alprazolam—Diarrhoea—Paclitaxel—kidney cancer	9.7e-05	0.000394	CcSEcCtD
Alprazolam—Feeling abnormal—Capecitabine—kidney cancer	9.59e-05	0.00039	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—kidney cancer	9.58e-05	0.000389	CcSEcCtD
Alprazolam—Gastrointestinal pain—Capecitabine—kidney cancer	9.52e-05	0.000387	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—kidney cancer	9.52e-05	0.000387	CcSEcCtD
Alprazolam—Chills—Doxorubicin—kidney cancer	9.47e-05	0.000385	CcSEcCtD
Alprazolam—Dizziness—Paclitaxel—kidney cancer	9.38e-05	0.000381	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—kidney cancer	9.25e-05	0.000376	CcSEcCtD
Alprazolam—Urticaria—Capecitabine—kidney cancer	9.25e-05	0.000376	CcSEcCtD
Alprazolam—Body temperature increased—Capecitabine—kidney cancer	9.2e-05	0.000374	CcSEcCtD
Alprazolam—Abdominal pain—Capecitabine—kidney cancer	9.2e-05	0.000374	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—kidney cancer	9.19e-05	0.000373	CcSEcCtD
Alprazolam—Tension—Doxorubicin—kidney cancer	9.02e-05	0.000366	CcSEcCtD
Alprazolam—Vomiting—Paclitaxel—kidney cancer	9.02e-05	0.000366	CcSEcCtD
Alprazolam—Rash—Paclitaxel—kidney cancer	8.94e-05	0.000363	CcSEcCtD
Alprazolam—Dermatitis—Paclitaxel—kidney cancer	8.93e-05	0.000363	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—kidney cancer	8.93e-05	0.000363	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—kidney cancer	8.89e-05	0.000361	CcSEcCtD
Alprazolam—Headache—Paclitaxel—kidney cancer	8.88e-05	0.000361	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—kidney cancer	8.84e-05	0.000359	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—kidney cancer	8.66e-05	0.000352	CcSEcCtD
Alprazolam—Hypersensitivity—Capecitabine—kidney cancer	8.57e-05	0.000348	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—kidney cancer	8.53e-05	0.000346	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—kidney cancer	8.45e-05	0.000343	CcSEcCtD
Alprazolam—Nausea—Paclitaxel—kidney cancer	8.42e-05	0.000342	CcSEcCtD
Alprazolam—Asthenia—Capecitabine—kidney cancer	8.35e-05	0.000339	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—kidney cancer	8.29e-05	0.000337	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—kidney cancer	8.26e-05	0.000336	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—kidney cancer	8.24e-05	0.000335	CcSEcCtD
Alprazolam—Pruritus—Capecitabine—kidney cancer	8.23e-05	0.000335	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—kidney cancer	8.12e-05	0.00033	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—kidney cancer	8.08e-05	0.000328	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—kidney cancer	7.96e-05	0.000324	CcSEcCtD
Alprazolam—Diarrhoea—Capecitabine—kidney cancer	7.96e-05	0.000323	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—kidney cancer	7.83e-05	0.000318	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—kidney cancer	7.83e-05	0.000318	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—kidney cancer	7.83e-05	0.000318	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—kidney cancer	7.8e-05	0.000317	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.77e-05	0.000316	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—kidney cancer	7.73e-05	0.000314	CcSEcCtD
Alprazolam—Dizziness—Capecitabine—kidney cancer	7.7e-05	0.000313	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—kidney cancer	7.65e-05	0.000311	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—kidney cancer	7.56e-05	0.000307	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—kidney cancer	7.5e-05	0.000305	CcSEcCtD
Alprazolam—Infection—Doxorubicin—kidney cancer	7.45e-05	0.000303	CcSEcCtD
Alprazolam—Vomiting—Capecitabine—kidney cancer	7.4e-05	0.000301	CcSEcCtD
Alprazolam—Shock—Doxorubicin—kidney cancer	7.38e-05	0.0003	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—kidney cancer	7.36e-05	0.000299	CcSEcCtD
Alprazolam—Rash—Capecitabine—kidney cancer	7.34e-05	0.000298	CcSEcCtD
Alprazolam—Dermatitis—Capecitabine—kidney cancer	7.33e-05	0.000298	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—kidney cancer	7.32e-05	0.000297	CcSEcCtD
Alprazolam—Headache—Capecitabine—kidney cancer	7.29e-05	0.000296	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—kidney cancer	7.29e-05	0.000296	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—kidney cancer	7.25e-05	0.000295	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—kidney cancer	7.15e-05	0.000291	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—kidney cancer	7.01e-05	0.000285	CcSEcCtD
Alprazolam—Nausea—Capecitabine—kidney cancer	6.91e-05	0.000281	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.83e-05	0.000278	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—kidney cancer	6.78e-05	0.000276	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—kidney cancer	6.74e-05	0.000274	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—kidney cancer	6.69e-05	0.000272	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—kidney cancer	6.67e-05	0.000271	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—kidney cancer	6.6e-05	0.000268	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—kidney cancer	6.52e-05	0.000265	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.48e-05	0.000263	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—kidney cancer	6.47e-05	0.000263	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—kidney cancer	6.41e-05	0.000261	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—kidney cancer	6.18e-05	0.000251	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—kidney cancer	6.13e-05	0.000249	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—kidney cancer	5.96e-05	0.000242	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—kidney cancer	5.93e-05	0.000241	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—kidney cancer	5.93e-05	0.000241	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—kidney cancer	5.53e-05	0.000225	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—kidney cancer	5.38e-05	0.000219	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—kidney cancer	5.31e-05	0.000216	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—kidney cancer	5.13e-05	0.000209	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—kidney cancer	4.96e-05	0.000202	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—kidney cancer	4.77e-05	0.000194	CcSEcCtD
Alprazolam—Rash—Doxorubicin—kidney cancer	4.73e-05	0.000192	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—kidney cancer	4.73e-05	0.000192	CcSEcCtD
Alprazolam—Headache—Doxorubicin—kidney cancer	4.7e-05	0.000191	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—kidney cancer	4.46e-05	0.000181	CcSEcCtD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	2.84e-05	0.00139	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTM1—kidney cancer	2.81e-05	0.00137	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	2.77e-05	0.00135	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PDHB—kidney cancer	2.76e-05	0.00135	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—POMC—kidney cancer	2.75e-05	0.00134	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—RAF1—kidney cancer	2.73e-05	0.00133	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	2.66e-05	0.0013	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	2.65e-05	0.0013	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.64e-05	0.00129	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	2.63e-05	0.00128	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	2.62e-05	0.00128	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.61e-05	0.00127	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	2.61e-05	0.00127	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CCBL1—kidney cancer	2.59e-05	0.00126	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—RAF1—kidney cancer	2.59e-05	0.00126	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.57e-05	0.00125	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	2.56e-05	0.00125	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—RAF1—kidney cancer	2.55e-05	0.00124	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.54e-05	0.00124	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.52e-05	0.00123	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—BRAF—kidney cancer	2.51e-05	0.00122	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	2.5e-05	0.00122	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.49e-05	0.00122	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.49e-05	0.00121	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.45e-05	0.00119	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.45e-05	0.00119	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—BRAF—kidney cancer	2.44e-05	0.00119	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.43e-05	0.00119	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.42e-05	0.00118	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.4e-05	0.00117	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—BRAF—kidney cancer	2.39e-05	0.00117	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.39e-05	0.00116	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—MAPK3—kidney cancer	2.39e-05	0.00116	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.38e-05	0.00116	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.36e-05	0.00115	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—BRAF—kidney cancer	2.35e-05	0.00115	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.35e-05	0.00115	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ACY1—kidney cancer	2.34e-05	0.00114	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.34e-05	0.00114	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—BRAF—kidney cancer	2.34e-05	0.00114	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.33e-05	0.00114	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	2.32e-05	0.00113	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.32e-05	0.00113	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	2.31e-05	0.00113	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.3e-05	0.00112	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—BRAF—kidney cancer	2.29e-05	0.00112	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.28e-05	0.00111	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	2.27e-05	0.00111	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GLIPR1—kidney cancer	2.25e-05	0.0011	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPAT—kidney cancer	2.25e-05	0.0011	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	2.18e-05	0.00107	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTP1—kidney cancer	2.16e-05	0.00105	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.15e-05	0.00105	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	2.13e-05	0.00104	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—RAF1—kidney cancer	2.09e-05	0.00102	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—FH—kidney cancer	2.09e-05	0.00102	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APRT—kidney cancer	2.09e-05	0.00102	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.09e-05	0.00102	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.05e-05	0.001	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—RAF1—kidney cancer	2.03e-05	0.000992	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	2.03e-05	0.000991	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.01e-05	0.000983	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—BRAF—kidney cancer	2e-05	0.000978	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—RAF1—kidney cancer	2e-05	0.000975	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PDHB—kidney cancer	1.99e-05	0.000973	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	1.99e-05	0.000973	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.99e-05	0.000971	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—POMC—kidney cancer	1.99e-05	0.00097	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTM1—kidney cancer	1.98e-05	0.000967	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GPC3—kidney cancer	1.96e-05	0.000959	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—RAF1—kidney cancer	1.96e-05	0.000958	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	1.95e-05	0.000954	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—RAF1—kidney cancer	1.95e-05	0.000952	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.93e-05	0.000943	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.92e-05	0.000938	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—RAF1—kidney cancer	1.91e-05	0.000934	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CA2—kidney cancer	1.91e-05	0.000933	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.9e-05	0.000926	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	1.88e-05	0.000917	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.87e-05	0.000915	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CCBL1—kidney cancer	1.87e-05	0.000914	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.87e-05	0.00091	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALAD—kidney cancer	1.86e-05	0.000909	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.85e-05	0.000904	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	1.85e-05	0.000904	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.82e-05	0.000888	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.82e-05	0.000888	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ST3GAL2—kidney cancer	1.82e-05	0.000887	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.79e-05	0.000872	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALDH1A1—kidney cancer	1.78e-05	0.000867	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.76e-05	0.000857	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.75e-05	0.000852	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.74e-05	0.000849	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.71e-05	0.000836	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PGK1—kidney cancer	1.7e-05	0.000831	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC5A3—kidney cancer	1.7e-05	0.000831	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—RAF1—kidney cancer	1.67e-05	0.000817	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LDHB—kidney cancer	1.67e-05	0.000815	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ACY1—kidney cancer	1.65e-05	0.000806	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPAT—kidney cancer	1.62e-05	0.000793	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GLIPR1—kidney cancer	1.62e-05	0.000793	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.59e-05	0.000776	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APRT—kidney cancer	1.51e-05	0.000737	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—FH—kidney cancer	1.51e-05	0.000737	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.5e-05	0.000731	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CA9—kidney cancer	1.45e-05	0.000707	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—MAPK1—kidney cancer	1.44e-05	0.000701	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.42e-05	0.000694	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GPC3—kidney cancer	1.42e-05	0.000693	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.41e-05	0.000688	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PDHB—kidney cancer	1.41e-05	0.000686	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.4e-05	0.000684	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—POMC—kidney cancer	1.4e-05	0.000683	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—MAPK1—kidney cancer	1.4e-05	0.000681	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CA2—kidney cancer	1.38e-05	0.000674	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—MAPK1—kidney cancer	1.37e-05	0.000668	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALAD—kidney cancer	1.35e-05	0.000657	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—MAPK1—kidney cancer	1.35e-05	0.000657	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—MAPK1—kidney cancer	1.34e-05	0.000653	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CCBL1—kidney cancer	1.32e-05	0.000645	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.31e-05	0.000641	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—MAPK1—kidney cancer	1.31e-05	0.000641	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.31e-05	0.000638	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.29e-05	0.000629	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.28e-05	0.000627	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.24e-05	0.000605	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CRABP1—kidney cancer	1.23e-05	0.000601	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PGK1—kidney cancer	1.23e-05	0.000601	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.23e-05	0.000601	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.22e-05	0.000596	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LDHB—kidney cancer	1.21e-05	0.000589	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.19e-05	0.000583	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—MAPK1—kidney cancer	1.15e-05	0.00056	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPAT—kidney cancer	1.15e-05	0.000559	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.15e-05	0.000559	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ITPR2—kidney cancer	1.14e-05	0.000559	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.13e-05	0.000552	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.13e-05	0.000549	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.12e-05	0.000546	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.09e-05	0.000534	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ACY1—kidney cancer	1.09e-05	0.000532	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.07e-05	0.000524	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—FH—kidney cancer	1.06e-05	0.00052	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APRT—kidney cancer	1.06e-05	0.00052	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.06e-05	0.000515	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.05e-05	0.000512	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CA9—kidney cancer	1.05e-05	0.000511	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ACHE—kidney cancer	1.04e-05	0.000509	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTT1—kidney cancer	1.04e-05	0.000509	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.04e-05	0.000508	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.03e-05	0.000502	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GPC3—kidney cancer	1e-05	0.000489	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SCARB1—kidney cancer	9.88e-06	0.000482	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS1—kidney cancer	9.78e-06	0.000477	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CA2—kidney cancer	9.74e-06	0.000475	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PSMD7—kidney cancer	9.59e-06	0.000468	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALAD—kidney cancer	9.49e-06	0.000463	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PDHB—kidney cancer	9.27e-06	0.000452	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ST3GAL2—kidney cancer	9.26e-06	0.000452	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—POMC—kidney cancer	9.24e-06	0.000451	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—BCHE—kidney cancer	9.1e-06	0.000444	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDH1A1—kidney cancer	9.05e-06	0.000442	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	9e-06	0.000439	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC5A5—kidney cancer	8.98e-06	0.000438	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CRABP1—kidney cancer	8.9e-06	0.000434	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CCBL1—kidney cancer	8.71e-06	0.000425	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PGK1—kidney cancer	8.68e-06	0.000424	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC5A3—kidney cancer	8.68e-06	0.000424	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC2A1—kidney cancer	8.68e-06	0.000423	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LDHB—kidney cancer	8.51e-06	0.000415	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ITPR2—kidney cancer	8.28e-06	0.000404	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.55e-06	0.000369	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPAT—kidney cancer	7.55e-06	0.000369	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—kidney cancer	7.55e-06	0.000368	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ACHE—kidney cancer	7.55e-06	0.000368	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CA9—kidney cancer	7.38e-06	0.00036	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—kidney cancer	7.24e-06	0.000353	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.21e-06	0.000352	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SCARB1—kidney cancer	7.14e-06	0.000349	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS1—kidney cancer	7.07e-06	0.000345	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APRT—kidney cancer	7.02e-06	0.000343	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—FH—kidney cancer	7.02e-06	0.000343	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PSMD7—kidney cancer	6.94e-06	0.000338	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCB1—kidney cancer	6.85e-06	0.000334	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—kidney cancer	6.65e-06	0.000325	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GPC3—kidney cancer	6.6e-06	0.000322	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—BCHE—kidney cancer	6.57e-06	0.000321	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.49e-06	0.000317	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CA2—kidney cancer	6.42e-06	0.000313	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.3e-06	0.000308	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CRABP1—kidney cancer	6.28e-06	0.000306	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.27e-06	0.000306	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALAD—kidney cancer	6.26e-06	0.000305	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.11e-06	0.000298	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.97e-06	0.000291	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ITPR2—kidney cancer	5.83e-06	0.000285	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.72e-06	0.000279	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PGK1—kidney cancer	5.72e-06	0.000279	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LDHB—kidney cancer	5.61e-06	0.000274	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.38e-06	0.000262	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—kidney cancer	5.32e-06	0.00026	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ACHE—kidney cancer	5.32e-06	0.00026	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—kidney cancer	5.23e-06	0.000255	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SCARB1—kidney cancer	5.04e-06	0.000246	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS1—kidney cancer	4.99e-06	0.000243	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCB1—kidney cancer	4.95e-06	0.000242	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PSMD7—kidney cancer	4.89e-06	0.000239	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CA9—kidney cancer	4.87e-06	0.000238	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—kidney cancer	4.81e-06	0.000235	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—POMC—kidney cancer	4.7e-06	0.000229	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—BCHE—kidney cancer	4.63e-06	0.000226	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.58e-06	0.000223	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.56e-06	0.000222	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.42e-06	0.000216	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.29e-06	0.000209	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CRABP1—kidney cancer	4.14e-06	0.000202	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ITPR2—kidney cancer	3.85e-06	0.000188	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—kidney cancer	3.75e-06	0.000183	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.74e-06	0.000183	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—kidney cancer	3.69e-06	0.00018	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ACHE—kidney cancer	3.51e-06	0.000171	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—kidney cancer	3.51e-06	0.000171	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCB1—kidney cancer	3.49e-06	0.00017	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—POMC—kidney cancer	3.4e-06	0.000166	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—kidney cancer	3.39e-06	0.000165	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SCARB1—kidney cancer	3.32e-06	0.000162	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS1—kidney cancer	3.29e-06	0.00016	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTEN—kidney cancer	3.27e-06	0.00016	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PSMD7—kidney cancer	3.22e-06	0.000157	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.21e-06	0.000157	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—BCHE—kidney cancer	3.06e-06	0.000149	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.02e-06	0.000147	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.92e-06	0.000142	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—kidney cancer	2.71e-06	0.000132	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.64e-06	0.000129	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—kidney cancer	2.43e-06	0.000119	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—POMC—kidney cancer	2.4e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTEN—kidney cancer	2.36e-06	0.000115	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.31e-06	0.000113	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCB1—kidney cancer	2.3e-06	0.000112	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—kidney cancer	2.23e-06	0.000109	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.12e-06	0.000103	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—kidney cancer	1.91e-06	9.32e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.67e-06	8.14e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTEN—kidney cancer	1.67e-06	8.13e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—POMC—kidney cancer	1.58e-06	7.71e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—kidney cancer	1.26e-06	6.15e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.18e-06	5.74e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTEN—kidney cancer	1.1e-06	5.36e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.75e-07	3.78e-05	CbGpPWpGaD
